CCYG Financials 07/16/2014 02:15:08 CellCyte Gene

CCYG Financials 07/16/2014 02:15:08
CellCyte Genetics Corp.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 124 133 307 756
Non-Recurring Items - - - -
Other - - - -
Operating Income (124) (133) (307) (756)
Income From Continuing Operations
Add'l Income/Expense Items - 752 - (5)
Earnings Before Interest and Tax (124) 619 (307) (761)
Interest Expense 40 33 53 38
Earnings Before Tax (164) 586 (359) (799)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (164) 1,335 (359) (799)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (164) 586 (359) (799)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (164) 586 (359) (799)